had final responsibility to submit for publication. The work described was carried out in accordance to International Committee of Medical Journal Editors (ICMJE) recommendations for conduct, reporting, editing and publications of scholarly work in medical journals. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
#RETROSPECTIVE RESEARCH FULL#
All authors had full access to the data and gave final approval before submission. All authors participated in the development of this article and in its critical review with important intellectual contributions. were involved in the design of the study. GlaxoSmithKline Biologicals SA also paid all costs associated with the development and publication of this article. GlaxoSmithKline Biologicals SA funded this study (GSK study identifier: HO-15-15728) and was involved in all stages of study conduct, including analysis of the data. was an employee of the GSK group of companies at the time of the conduct of the study and held shares in the GSK group of companies as part of his employee remuneration. also report research grants to their institution from the GSK group of companies and from other pharmaceutical and biotech companies outside the submitted work. Truven Health Analytics received research grant from the GSK group of companies for the study conduct. are employees of Truven Health Analytics, an IBM Company. is an employee of the GSK group of companies and holds shares in the GSK group of companies as part of his employee remuneration. Rahul Shenolikar, PhD, is currently at AstraZeneca, Gaithersburg, MD. From the *GSK, Philadelphia, Pennsylvania †Truven Health Analytics, an IBM Company, Bethesda, Maryland ‡GSK, Research Triangle Park, North Carolina and §Truven Health Analytics, an IBM Company, Durham, North Carolina.
0 kommentar(er)
